GENFIT S.A. (GNFT) Social Stream

GENFIT S.A. (GNFT): $4.53

-0.10 (-2.16%)

POWR Rating

Component Grades













Add GNFT to Watchlist
Sign Up

Industry: Biotech


of 481

in industry

Featured Post From StockTwits About GNFT

$HDSN 🚨 Hit: $2.64 Β· 80.8% in 15 days 🚨 It reached $2.64 in premarket but came back down to its usual trading range throughout the day. I just wish people had abandoned any broker that wouldn't let them trade before 9. Just like I share my thoughts on a few potential runners at the end of the day, here's a list of stocks that could be the next runner with a short dd for each πŸ‘‡πŸ’ΈπŸš¨

$GNFT Signed an agreement with LabCorp to market the test in 09/2020 to begin distribution in 2021
$HEPA Partnered with ENDRA Life Sciences to drive efficiencies in NASH clinical trials
$CIDM Positive earnings updates include increased revenues and licensing sales, debt reduction, acquisitions, partnerships, and so on. Recommend reading the financial and operational highlights released
$PED WTI is rising, Texas is hit by the worst snowstorm that has brought down the use of refineries from 83 to 56% and the general increase in demand is going to work well for this company
Investar_, published March 18, 2021

What Else are GNFT Traders Talking About?

Other tickers frequently mentioned alongside GNFT is HDSN.

Other Notable StockTweets About GNFT

There are a lot of good opportunities out there to buy the dips for a massive gain. Those who bought the fear, which is never easy, have been rewarded in a very short time - NAK ran 88% in 1 day, STG ran 24% in 5 days, YVR ran 32% in 4 days, CFMS ran 70% in 3 days, HDSN ran 47% in 1 day, and the list goes on. I'm new to Stocktwits, but I'm not new to the market. Here's a list of the stocks with some brief dd for each that could take off as the market shows more signs of recovery from the hit. I would like to share my thoughts on as many good setups as possible, and hopefully help others by doing so (1/n) πŸ™πŸ€πŸš¨

$PIRS Works on asthma treatment with the revenue growth of 45% per year over the last 5 years
$GNFT Signed an agreement with LabCorp to market the test in 09/2020 to begin distribution in 2021
$CYRN Expanded anti-phishing security solution availability via Azure
$CATB Announced an acquisition of Quellis Biopharma focused on discovering molecules for serious rare disease

Investar_, published March 6, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 2.1932 seconds.